Effect of Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation(TMS) on Brain Derived Neurotrophic Factor (BDNF) in Depressed Patients.

NCT00630123 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2015-12-16

No results posted yet for this study

Summary

To investigate the change in brain derived neurotrophic factor (BDNF) between pre and post treatment for patients with depression with either ECT or TMS.

Conditions

Sponsors & Collaborators

  • Queen's University

    lead OTHER

Principal Investigators

  • Roumen Milev, MD, FRCP(C) · Queen's University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00630123 on ClinicalTrials.gov